{"id":52830,"date":"2023-01-11T23:02:16","date_gmt":"2023-01-11T22:02:16","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/"},"modified":"2023-01-11T23:02:16","modified_gmt":"2023-01-11T22:02:16","slug":"elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/","title":{"rendered":"Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 25, 2023"},"content":{"rendered":"<div>\n<p>INDIANAPOLIS&#8211;(BUSINESS WIRE)&#8211;Elevance Health <b>(NYSE: ELV) <\/b>will release fourth quarter 2022 financial results on January 25, 2023, at 6:00 a.m. Eastern Standard Time (\u201cEST\u201d). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n888-947-9963 (Domestic)\n<\/li>\n<li>\n312-470-0178 (International)\n<\/li>\n<li>\n800-396-1242 (Domestic Replay)\n<\/li>\n<li>\n203-369-3272 (International Replay)\n<\/li>\n<\/ul>\n<p>\nThe access code for the call is <b>3972058<\/b>. There is no access code for the replay. The replay will be available from 11:30 a.m. EST on January 25, 2023 until the end of the day on February 24, 2023. The call will also be available through a live webcast at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.elevancehealth.com&amp;esheet=53203942&amp;newsitemid=20230111005862&amp;lan=en-US&amp;anchor=www.elevancehealth.com&amp;index=1&amp;md5=98333255ee72f0fd6fea053fef5fa412\" rel=\"nofollow noopener\" shape=\"rect\">www.elevancehealth.com<\/a> under the \u201cInvestors\u201d link. A webcast replay will be available following the call.\n<\/p>\n<p>\n<b>About Elevance Health, Inc.<\/b>\n<\/p>\n<p>\nElevance Health is a lifetime, trusted health partner fueled by its purpose to improve the health of humanity. The company supports consumers, families, and communities across the entire care journey \u2013 connecting them to the care, support, and resources they need to lead healthier lives. Elevance Health\u2019s companies serve more than 119 million people through a diverse portfolio of industry-leading medical, digital, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.elevancehealth.com%2F&amp;esheet=53203942&amp;newsitemid=20230111005862&amp;lan=en-US&amp;anchor=www.elevancehealth.com&amp;index=2&amp;md5=0b63bfb6726a1f8eb9791229e2efe901\" rel=\"nofollow noopener\" shape=\"rect\">www.elevancehealth.com<\/a> or follow us @ElevanceHealth on Twitter and Elevance Health on LinkedIn.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media Contact:<\/b><br \/>Leslie Porras<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;o&#x3a;&#76;&#x65;&#115;&#x6c;&#105;e&#x2e;P&#x6f;r&#x72;&#97;&#x73;&#64;&#x65;&#108;&#x65;&#118;a&#x6e;c&#x65;h&#x65;&#97;&#x6c;&#116;&#x68;&#46;&#x63;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x4c;&#x65;&#x73;&#x6c;&#x69;&#x65;&#x2e;&#x50;&#x6f;&#x72;&#x72;&#97;&#115;&#64;&#101;&#108;&#101;&#118;ancehe&#x61;&#x6c;&#x74;&#x68;&#x2e;&#x63;&#x6f;&#x6d;<\/a>\n<\/p>\n<p>\n<b>Investor Relations:<\/b><br \/>Stephen Tanal<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#83;&#116;&#101;&#112;&#104;en&#46;T&#x61;&#x6e;&#x61;&#x6c;&#x40;&#x65;&#x6c;&#x65;&#118;&#97;&#110;&#99;&#101;&#46;com\" rel=\"nofollow noopener\" shape=\"rect\">Step&#104;&#101;&#110;&#46;&#84;&#97;&#110;&#x61;&#x6c;&#x40;&#x65;&#x6c;&#x65;&#x76;&#x61;&#x6e;cehe&#97;&#108;&#116;&#104;&#46;&#99;&#111;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>INDIANAPOLIS&#8211;(BUSINESS WIRE)&#8211;Elevance Health (NYSE: ELV) will release fourth quarter 2022 financial results on January 25, 2023, at 6:00 a.m. Eastern Standard Time (\u201cEST\u201d). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52830","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 25, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 25, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"INDIANAPOLIS&#8211;(BUSINESS WIRE)&#8211;Elevance Health (NYSE: ELV) will release fourth quarter 2022 financial results on January 25, 2023, at 6:00 a.m. Eastern Standard Time (\u201cEST\u201d). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-11T22:02:16+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 25, 2023\",\"datePublished\":\"2023-01-11T22:02:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\\\/\"},\"wordCount\":256,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\\\/\",\"name\":\"Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 25, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2023-01-11T22:02:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 25, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 25, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/","og_locale":"en_US","og_type":"article","og_title":"Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 25, 2023 - Pharma Trend","og_description":"INDIANAPOLIS&#8211;(BUSINESS WIRE)&#8211;Elevance Health (NYSE: ELV) will release fourth quarter 2022 financial results on January 25, 2023, at 6:00 a.m. Eastern Standard Time (\u201cEST\u201d). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-11T22:02:16+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 25, 2023","datePublished":"2023-01-11T22:02:16+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/"},"wordCount":256,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/","url":"https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/","name":"Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 25, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2023-01-11T22:02:16+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/elevance-health-to-hold-conference-call-and-webcast-to-discuss-fourth-quarter-results-on-january-25-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 25, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52830","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52830"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52830\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52830"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52830"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52830"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}